[1]
|
V. Cheynier, “Polyphenols in Foods Are More Complex Than Often Thought,” The American Journal of Clinical Nutrition, Vol. 81, No. 1, 2005, pp. 223S-229S.
|
[2]
|
A. Scalbert, A. C.Manach, C. Morand, C. Remesy and L. Jimenez, “Dietary Polyphenols and the Prevention of Diseases,” Critical Reviews in Food Science and Nutrition, Vol. 45, No. 4, 2005, pp. 287-306.
doi:10.1080/1040869059096
|
[3]
|
I. Naasani, F. Oh-Hashi, T. Oh-Hara, W.Y. Feng, J. Johnston, K. Chan and T. Tsuruo, “Blocking Telomerase by Dietary Polyphenols Is a Major Mechanism for Limiting the Growth of Human Cancer Cells in Vitro and in Vivo,” Cancer Research, Vol. 63, No. 4, 2003, pp. 824-830.
|
[4]
|
T. Hussain, S. Gupta, V. M. Adhami and H. Mukhtar, “Green Tea Constituent Epigallocatechin-3-Gallate Selectively Inhibits COX-2 without Affecting COX-1 Expression in Human Prostate Carcinoma Cells,” International Journal of Cancer, Vol. 113, No. 4, 2005, pp. 660-669.
doi:10.1002/ijc.20629
|
[5]
|
K.A. O’Leary, S. De Pascual-Tereasa, P. W. Needs, Y. P. Bao, N. M. O’Brien and G. Williamson, “Effect of Flavonoids and Vitamin E on Cyclooxygenase-2 (COX-2) Transcription,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 551, No. 1-2, 2004, pp. 245-254. doi:10.1016/j.mrfmmm.2004.01.015
|
[6]
|
C. D. Sadik, H. Sies and T. Schewe, “Inhibition of 15-Lipoxygenases by Flavonoids: Structure-Activity Relations and Mode of Action,” Biochemical Pharmacology, Vol. 65, No. 5, 2003, pp. 773-781.
doi:10.1016/S0006-2952(02)01621-0
|
[7]
|
T. Schewe, C. Sadik, L. O. Klotz, T. Yoshimoto, H. Kuhn and H. Sies, “Polyphenols of Cocoa: Inhibition of Mammalian 15-Lipoxygenase,” Biological Chemistry, Vol. 382, No. 12, 2001, pp. 1687-1696.
doi:10.1515/BC.2001.204
|
[8]
|
S. Wiseman, T. Mulder and A. Rietveld, “Tea Flavonoids: Bioavailability in Vivo and Effects on Cell Signalling Pathways in Vitro,” Antioxidants & Redox Signaling, Vol. 3, No. 6, 2001, pp. 1009-1021.
doi:10.1089/152308601317203549
|
[9]
|
D. F. Birt, S. Hendrich and W. Wang, “Dietary Agents in Cancer Prevention: Flavonoids and Isoflavonoids,” Pharmacology & Therapeutics, Vol. 90, No. 2-3, 2001, pp. 157-177.
|
[10]
|
P. M. Kris-Etherton and C. L. Keen, “Evidence That the Antioxidant Flavonoids in Tea and Cocoa Are Beneficial for Cardiovascular Health,” Current Opinion in Lipidology, Vol. 13, No. 1, 2002, pp. 1341-1349.
doi:10.1097/00041433-200202000-00007
|
[11]
|
M. Artico, R. Di Santo, R. Costi, E. Novellino, G. Greco, S. Massa, et al., “Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase: Synthesis, Biological Evaluation, and Molecular Modeling,” Journal of Medicinal Chemistry, Vol. 41, No. 21, 1998, pp. 3948-3960. doi:10.1021/jm9707232
|
[12]
|
H. K. Biesalski, “Polyphenols and Inflammation: Basic Interactions,” Current Opinion in Clinical Nutrition & Metabolic Care, Vol. 10, No. 6, 2007, pp. 724-728.
doi:10.1097/MCO.0b013e3282f0cef2
|
[13]
|
I. Rahman, S. K. Biswas and P. A. Kirkham, “Regulation of Inflammation and Redox Signalling by Dietary Polyphenols,” Biochemical Pharmacology, Vol. 72, No. 11, 2006, pp. 1439-1452. doi:10.1016/j.bcp.2006.07.004
|
[14]
|
C. Manach, A. Mazur and A. Scalbert, “Polyphenols and Prevention of Cardiovascular Disease,” Current Opinion in Lipidology, Vol. 16, No. 1, 2005, pp. 77-84.
doi:10.1097/00041433-200502000-00013
|
[15]
|
C. L. Hsu and G. C. Yen, “Phenolic Compounds: Evidence for Inhibitory Effects against Obesity and Their Underlying Molecular Signalling Mechanisms,” Molecular Nutrition & Food Research, Vol. 52, No. 1, 2008, pp. 53-61. doi:10.1002/mnfr.200700393
|
[16]
|
K. M. Nicholson and N. G. Anderson, “The Protein Kinase B/Akt Signalling Pathway in Human Malignancy,” Cellular Signalling, Vol. 14, No. 5, 2002, pp. 381-395.
doi:10.1016/S0898-6568(01)00271-6
|
[17]
|
M. Viroli and M. Casadei, “Biochemical Tuple Spaces for Self-Organising Coordination,” In: J. Field and V. T. Vasconcelos, Eds., Coordination Languages and Models, ser. LNCS, Springer, Lisbon, 2009, pp. 143-162.
doi:10.1007/978-3-642-02053-7_8
|
[18]
|
A. Omicini and E. Denti, “From Tuple Spaces to Tuple Centres,” Science of Computer Programming, Vol. 41, No. 3, 2001, pp. 277-294.
doi:10.1016/S0167-6423(01)00011-9
|
[19]
|
A. Omicini and F. Zambonelli, “Coordination for Internet Application Development,” Autonomous Agents and Multi- Agent Systems, Vol. 2, No. 3, 1999, pp. 251-269,
doi:10.1023/A:1010060322135
|
[20]
|
D. Gelernter, “Generative Communication in Linda,” ACM Transactions on Programming Languages and Systems, Vol. 7, No. 1, 1985, pp. 80-112.
http://portal.acm.org/citation.cfm?id=2433
|
[21]
|
P. P. González-Pérez, A. Omicini and M. Sbaraglia, “A Biochemically-Inspired Coordination-Based Model for Simulating Intracellular Signalling Pathways,” Journal of Simulation, Vol. 2013, No. I-II, 2013.
doi:10.1057/jos.2012.28
|
[22]
|
D. T. Gillespie, “Exact Stochastic Simulation of Coupled Chemical Reactions,” The Journal of Physical Chemistry, Vol. 81, No. 25, 1977, pp. 2340-2361.
doi:10.1021/j100540a008
|
[23]
|
O. Tokgun, H. Akca, R. Mammadov, C. Aykurt and G. Deniz, “Convolvulus galaticus, Crocus antalyensis, and Lilium candidum Extracts Show Their Antitumor Activity Through Induction of p53-Mediated Apoptosis on Human Breast Cancer Cell Line MCF-7,” Journal of Medicinal Food, Vol. 15, No. 11, 2012, pp. 1000-1005.
doi:10.1089/jmf.2012.0050
|
[24]
|
L. S. Po, T. T. Wang, Z. Y. Chen and L. K. Leung, “Genistein-Induced Apoptosis in MCF-7 Cells Involves Changes in Bak and Bcl-x without Evidence of Anti-Oestrogenic Effects,” British Journal of Nutrition, Vol. 88, No. 5, 2002 pp. 463-469. doi:10.1079/BJN2002693
|
[25]
|
Y. J. Surh, “Cancer Chemoprevention with Dietary Phytochemicals,” Nature Reviews Cancer, Vol. 3, No. 10, 2003 pp. 768-780. doi:10.1038/nrc1189
|
[26]
|
D. L. Smith, L. K. Nolden, G. B. Mills and Y. Lu, “Chemo- and Radiosensitization Through Inhibition of PI3K/Akt Signaling,” In: D. A. Gewirtz, S. E. Holt and S. Grant, Eds., Apoptosis, Senescence and Cancer, Humana Press, New Jersey, 2007, pp. 313-334.
doi:10.1007/978-1-59745-221-2_17
|
[27]
|
W. Vanden Berghe, “Epigenetic Impact of Dietary Polyphenols in Cancer Chemoprevention: Lifelong Remodeling of Our Epigenomes,” Pharmacological Research, Vol. 65, No. 6, 2012, pp. 565-576.
doi:10.1016/j.phrs.2012.03.007
|
[28]
|
G. Kroemer, L. Galluzzi and C. Brenner, “Mitochondrial Membrane Permeabilization in Cell Death,” Physiological Reviews, Vol. 87, No. 1, 2007, pp. 99-163.
doi:10.1152/physrev.00013.2006
|
[29]
|
J. Hoshino, E. J. Park, T. P. Kondratyuk, L. Marler, J. M. Pezzuto, R. B. van Breemen, S. Mo, Y. Li and M. Cushman, “Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites,” Journal of Medicinal Chemistry, Vol. 53, No. 13, 2010, pp. 5033- 5043. doi:10.1021/jm100274c
|
[30]
|
G. Lauritzen, C. M. Stock, J. Lemaire, S. F. Lund, M. F. Jensen, B. Damsgaard, K. S. Petersen, M. Wiwel, L. R?n-nov-Jessen, A. Schwab and S. F. Pedersen, “The Na+/H+ Exchanger NHE1, But Not the Na+, HCO3(-) Cotransporter NBCn1, Regulates Motility of MCF7 Breast Cancer Cells Expressing Constitutively Active ErbB2,” Cancer Letters, Vol. 317, No. 2, 2012, pp. 172-183.
|
[31]
|
K. Yu, L. Toral-Barza, C. Shi, W. G. Zhang and A. Zask, “Response and Determinants of Cancer Cell Susceptibility to PI3K Inhibitors,” Cancer Biology & Therapy, Vol. 7, No. 2, 2008, pp. 307-315. doi:10.4161/cbt.7.2.5334
|
[32]
|
G. Gao, C. Chen, Y. Yang, H. Yang, J. Wang, Y. Zheng, Q. Huang and X. Hu, “Targeted Detecting HER2 Expression with Recombinant Anti HER2 ScFv-GFP Fusion Antibody,” Sheng Wu Gong Cheng Xue Bao, Vol. 28, No. 8, 2012, pp. 1002-1014.
|
[33]
|
T. Wang, M. Zhang, Z. Ma, K. Guo, V. Tergaonkar, Q. Zeng and W. Hong, “A Role of Rab7 in Stabilizing EGFR-Her2 and in Sustaining Akt Survival Signal,” Journal of Cellular Physiology, Vol. 2227, No. 6, 2012, pp. 2788-2797. doi:10.1002/jcp.23023
|
[34]
|
C. Mitchell, M. A. Park, G. Zhang, A. Yacoub, D. T. Curiel, P. B. Fisher, J. D. Roberts, S. Grant, P. Dent and C. Mol, “Extrinsic Pathway- and Cathepsin-Dependent Induction of Mitochondrial Dysfunction Are Essential for Synergistic Flavopiridol and Vorinostat Lethality in Breast Cancer Cells,” Cancer Therapy Journal, Vol. 12, No. 1, 2007, pp. 3101-3112.
doi:10.1158/1535-7163.MCT-07-0561
|
[35]
|
X. He, Y. Wang, J. Zhu, M. Orloff and C. Eng, “Resveratrol Enhances the Anti-Tumor Activity of the mTOR Inhibitor Rapamycin in Multiple Breast Cancer Cell Lines Mainly by Suppressing Rapamycin-Induced AKT Signaling,” Cancer Letters, Vol. 301, No. 2, 2011, pp. 168- 176. doi:10.1016/j.canlet.2010.11.012
|
[36]
|
A. D. Balgi, G. H. Diering, E. Donohue, K. K. Lam, B. D. Fonseca, C. Zimmerman, M. Numata and M. Roberge, “Regulation of mTORC1 Signaling by pH,” Plos One, Vol. 6, No. 6, 2011, e21549.
|
[37]
|
C. Garofalo, D. Sisci and E. Surmacz, “Leptin Interferes with the Effects of the Antiestrogen ICI 182,780 in MCF-7 Breast Cancer Cells,” Clinical Cancer Research, Vol. 10, No. 19, 2004, pp. 6466-6475.
doi:10.1158/1078-0432.CCR-04-0203
|
[38]
|
W. Wang, E. R. Rayburn, S. E. Velu, D. H. Nadkarni, S. Murugesan and R. Zhang, “In Vitro and in Vivo Anticancer Activity of Novel Synthetic Makaluvamine Analogues,” Clinical Cancer Research, Vol. 15, No. 10, 2009, pp. 3511-3518. doi:10.1158/1078-0432.CCR-08-2689
|
[39]
|
T. Sakamoto, H. Horiguchi, E. Oguma and F. Kayama, “Effects of Diverse Dietary Phytoestrogens on Cell Growth, Cell Cycle and Apoptosis in Estrogen-Receptor- Positive Breast Cancer Cells,” The Journal of Nutritional Biochemistry, Vol. 21, No. 9, 2012, pp. 856-864.
doi:10.1016/j.jnutbio.2009.06.010
|
[40]
|
L.Q Li, X. L. Li, L. Wang, W. J. Du, R. Guo, H. H. Liang, X. Liu, D. S. Liang, Y. J. Lu, H. L. Shan and H. C. Jiang, “Matrine Inhibits Breast Cancer Growth via miR-21/ PTEN/Akt Pathway in MCF-7 Cells,” Cellular Physiology and Biochemistry, Vol. 30, No. 3, 2012, pp. 631-641.
doi:10.1159/000341444
|
[41]
|
M. S. Sheikh, M. Garcia, Q. Zhan, Y. Liu and A. J. Fornace Jr., “Cell Cycle-Independent Regulation of p21-Waf1/Cip1 and Retinoblastoma Protein during Okadaic Acid-Induced Apoptosis Is Coupled with Induction of Bax Protein in Human Breast Carcinoma Cells,” Cell Growth & Differentiation, Vol. 7, No. 12, 1996, pp. 1599- 1607.
|